Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Prince

Showing results (51-60 of 151) with videos related to

Pageof 16
Sort By:
Cell Transplantation|May 1, 1996
Blood stem cell collection: factors influencing the recovery of granulocyte-macrophage colony forming cellsK Imrie, A K Stewart, R M Crump, et al.
Clinical and Experimental Dermatology|December 2, 2006
Long-term clearance of patch-stage mycosis fungoides with the 308-nm laserE Upjohn, P Foley, P Lane, et al.
Australian and New Zealand Journal of Medicine|June 27, 2000
Fludarabine and high dose cytarabine (FLA): a well tolerated salvage regimen in acute myeloid leukaemiaA H Strickland, C Seymour, H M Prince, et al.
Internal Medicine Journal|April 18, 2009
Safety and efficacy results from an international expanded access programme to bortezomib for patients with relapsed and/or refractory multiple myeloma: a subset analysis of the Australian and New Zealand data of 111 patientsH Quach, N Horvath, P Cannell, et al.
European Journal of Haematology|February 14, 2004
A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myelomaL Mileshkin, R Blum, J F Seymour, et al.
Clinical Lymphoma|November 15, 2001
Primary large-cell non-Hodgkin's lymphoma of the testis: a retrospective analysis of patterns of failure and prognostic factorsJ F Seymour, B Solomon, M M Wolf, et al.
Blood Cancer Journal|September 9, 2017
Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directionsC A van der Weyden, S A Pileri, A L Feldman, et al.
The British Journal of Dermatology|March 16, 2007
Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patientsM S Y Goh, C McCormack, H V Dinh, et al.
Gynecologic Oncology|May 2, 2001
Repetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer: results of a Phase I studyH M Prince, D Rischin, M Quinn, et al.
American Journal of Hematology|August 13, 2004
Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignanciesC S Tam, J Galanos, J F Seymour, et al.
Pageof 16

Showing results (51-60 of 151) with videos related to

Sort By:
Pageof 16
Cell Transplantation|May 1, 1996
Blood stem cell collection: factors influencing the recovery of granulocyte-macrophage colony forming cellsK Imrie, A K Stewart, R M Crump, et al.
Clinical and Experimental Dermatology|December 2, 2006
Long-term clearance of patch-stage mycosis fungoides with the 308-nm laserE Upjohn, P Foley, P Lane, et al.
Australian and New Zealand Journal of Medicine|June 27, 2000
Fludarabine and high dose cytarabine (FLA): a well tolerated salvage regimen in acute myeloid leukaemiaA H Strickland, C Seymour, H M Prince, et al.
Internal Medicine Journal|April 18, 2009
Safety and efficacy results from an international expanded access programme to bortezomib for patients with relapsed and/or refractory multiple myeloma: a subset analysis of the Australian and New Zealand data of 111 patientsH Quach, N Horvath, P Cannell, et al.
European Journal of Haematology|February 14, 2004
A comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myelomaL Mileshkin, R Blum, J F Seymour, et al.
Clinical Lymphoma|November 15, 2001
Primary large-cell non-Hodgkin's lymphoma of the testis: a retrospective analysis of patterns of failure and prognostic factorsJ F Seymour, B Solomon, M M Wolf, et al.
Blood Cancer Journal|September 9, 2017
Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directionsC A van der Weyden, S A Pileri, A L Feldman, et al.
The British Journal of Dermatology|March 16, 2007
Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patientsM S Y Goh, C McCormack, H V Dinh, et al.
Gynecologic Oncology|May 2, 2001
Repetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer: results of a Phase I studyH M Prince, D Rischin, M Quinn, et al.
American Journal of Hematology|August 13, 2004
Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignanciesC S Tam, J Galanos, J F Seymour, et al.
Pageof 16